Primary Prevention ICD French Registry

N/ACompletedNCT01992458

Clinique Pasteur5,576 enrolled

Overview

The indication of implantable cardioverter defibrillator (ICD) therapy for primary prevention of sudden cardiac death has been introduced later in France than in other parts of the World. Overall, we aimed to assess the risk-benefit ratio of this strategy over a 10 year period.

Study Type

OBSERVATIONAL

Enrollment

5,576

Conditions

Evaluation of Primary Prevention ICD in Real Life

Eligibility

Sex: ALL

Medical Language ↔ Plain English

Inclusion Criteria: * Coronary artery disease or dilated cardiomyopathy with low ejection fraction implanted with an ICD in the setting of primary prevention (criteria at the discretion of the physician) Exclusion Criteria: * Setting of secondary prevention * Other cardiopathies such as congenital, channelopathies, valvulopathies

Locations (1)

Clinique Pasteur

Toulouse, France

Outcomes

Primary Outcomes

Incidences of Appropriate Therapies (ATP and Shocks) and ICD-Related Complications

Time frame: 3-year

Secondary Outcomes

Cause-of-Death Analysis

Time frame: 3-year

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.